Free Trial

Dorsey Wright & Associates Has $2.84 Million Holdings in Relx Plc (NYSE:RELX)

Relx logo with Computer and Technology background

Dorsey Wright & Associates decreased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 10.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,235 shares of the technology company's stock after selling 6,793 shares during the quarter. Dorsey Wright & Associates' holdings in Relx were worth $2,835,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Ameriprise Financial Inc. grew its position in Relx by 368.7% during the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Northern Trust Corp increased its stake in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after buying an additional 745,532 shares during the period. GAMMA Investing LLC raised its holdings in Relx by 6,125.5% in the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company's stock valued at $34,232,000 after buying an additional 668,165 shares during the last quarter. Bank of Montreal Can raised its holdings in Relx by 290.3% in the 4th quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock valued at $40,277,000 after buying an additional 659,547 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after buying an additional 658,655 shares during the period. Institutional investors own 15.02% of the company's stock.

Relx Trading Up 1.2%

NYSE RELX traded up $0.64 during mid-day trading on Thursday, reaching $53.73. 1,383,100 shares of the stock were exchanged, compared to its average volume of 902,700. The stock has a market cap of $98.68 billion, a P/E ratio of 28.88, a P/E/G ratio of 3.46 and a beta of 0.83. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a one year low of $43.45 and a one year high of $56.33. The stock has a 50 day simple moving average of $53.67 and a 200-day simple moving average of $51.30.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on RELX shares. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They issued a "buy" rating on the stock. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Relx currently has a consensus rating of "Buy".

Check Out Our Latest Stock Analysis on Relx

About Relx

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Featured Articles

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines